Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients

Aldehyde dehydrogenase 2 (ALDH2) Glu504Lys variant was an independent risk factor for acute coronary syndrome (ACS). However, there are lacking researches about the relationship between the variant and prognosis of ACS. In the prospective study, 377 ACS patients were grouped into the wild‐type (*1/*...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Chang, Zhao, Yu, Bian, Yuan, Shang, Rui, Wang, Jia‐li, Xue, Li, Wei, Shu‐jian, Zhang, He, Chen, Yu‐guo, Xu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867093/
https://www.ncbi.nlm.nih.gov/pubmed/29441687
http://dx.doi.org/10.1111/jcmm.13536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867093/
https://www.ncbi.nlm.nih.gov/pubmed/29441687
http://dx.doi.org/10.1111/jcmm.13536

Ejemplares similares